Immunologists prepare for fraud fallout

Scientists and journals say fired MIT researcher's misconduct raises concerns about multiple papers

Written byJack Lucentini
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Immunologists are gearing up for a lengthy clean-up of research literature after the Massachusetts Institute of Technology (MIT) in Cambridge fired an immunologist for allegedly fabricating data—an incident they say may raise questions about all of his publications. Still, researchers who commented this week on the incident said that, for now, it doesn't seem to have affected their own findings.

On Oct. 27, MIT announced it had fired Luk van Parijs, an associate professor in biology, after he admitted fabricating data in a paper and several manuscripts and grant applications. Colleagues said van Parijs, who co-authored more than 30 published papers on immunology and RNA interference, was an emerging heavyweight.

Learning of alleged misconduct "in somebody with such a broad number of scientific contributions … is really scary," Isabel Merida of the National Biotechnology Center in Madrid, whose publications cited some of the findings under investigation, told The Scientist. "It ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Accelerating Recombinase Reprogramming with Machine Learning

Accelerating Recombinase Reprogramming with Machine Learning

Genome Modeling and Design: From the Molecular to Genome Scale

Genome Modeling and Design: From the Molecular to Genome Scale

Twist Bio 
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

DNA and pills, conceptual illustration of the relationship between genetics and therapeutic development

Multiplexing PCR Technologies for Biopharmaceutical Research

Thermo Fisher Logo

Products

waters-logo

Waters and BD's Biosciences & Diagnostic Solutions Business to Combine, Creating a Life Science and Diagnostics Leader Focused on Regulated, High-Volume Testing

zymo-research-logo

Zymo Research Partners with Harvard University to Bring the BioFestival to Cambridge, Empowering World-class Research

10x-genomics-logo

10x Genomics and A*STAR Genome Institute of Singapore Launch TISHUMAP Study to Advance AI-Driven Drug Target Discovery

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA